Exhibit 99.2
Brighthouse Financial, Inc.
Financial Supplement
Third Quarter 2021
Table of Contents | Financial Results | ||||||||||
Earnings and Select Metrics from Business Segments and Corporate & Other | |||||||||||
Other Information | |||||||||||
Appendix | |||||||||||
A-2 | |||||||||||
A-6 | |||||||||||
A-7 | Reconciliation of Net Income (Loss) Available to Shareholders to Adjusted Earnings and Adjusted Earnings, Less Notable Items, and Reconciliation of Net Income (Loss) Available to Shareholders per Common Share to Adjusted Earnings per Common Share and Adjusted Earnings, Less Notable Items per Common Share | ||||||||||
A-8 | |||||||||||
A-9 | |||||||||||
A-10 |
Note: See the Appendix for non-GAAP financial information, definitions and reconciliations. Financial information, unless otherwise noted, is rounded to millions. Some financial information, therefore, may not sum to the corresponding total.
As used in this financial supplement, “Brighthouse Financial,” “Brighthouse,” the “Company,” “we,” “our” and “us” refer to Brighthouse Financial, Inc.
Financial Results
Financial Supplement | 1 |
Key Metrics (Unaudited, dollars in millions except per share amounts)
As of or For the Three Months Ended | |||||||||||||||||||||||||||||||||||
Financial Results and Metrics (1) | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | ||||||||||||||||||||||||||||||
Net income (loss) available to shareholders | $361 | $10 | $(610) | $(1,045) | $(3,012) | ||||||||||||||||||||||||||||||
Adjusted earnings | $450 | $435 | $385 | $189 | $(689) | ||||||||||||||||||||||||||||||
Adjusted earnings, less notable items (2) | $514 | $458 | $428 | $272 | $388 | ||||||||||||||||||||||||||||||
Total corporate expenses (3) | $222 | $218 | $203 | $236 | $204 | ||||||||||||||||||||||||||||||
Combined total adjusted capital (4) | $9,700 | $9,432 | $9,421 | $8,617 | $8,432 | ||||||||||||||||||||||||||||||
Combined risk-based capital ratio (4), (5) | 520%-540% | 480%-500% | 500%-520% | 487% | 525%-545% | ||||||||||||||||||||||||||||||
Stockholders' Equity | |||||||||||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s stockholders’ equity | $16,031 | $16,115 | $15,017 | $18,023 | $18,266 | ||||||||||||||||||||||||||||||
Less: Preferred stock, net | 1,360 | 1,360 | 1,360 | 1,360 | 802 | ||||||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s common stockholders’ equity, including AOCI | $14,671 | $14,755 | $13,657 | $16,663 | $17,464 | ||||||||||||||||||||||||||||||
Less: AOCI | 4,290 | 4,596 | 3,389 | 5,716 | 5,381 | ||||||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s common stockholders’ equity, excluding AOCI | $10,381 | $10,159 | $10,268 | $10,947 | $12,083 | ||||||||||||||||||||||||||||||
Return on Common Equity (1) | |||||||||||||||||||||||||||||||||||
Return on common equity | (8.3)% | (28.2)% | (37.9)% | (6.1)% | (6.3)% | ||||||||||||||||||||||||||||||
Return on common equity, excluding AOCI | (11.9)% | (39.7)% | (50.7)% | (8.1)% | (8.0)% | ||||||||||||||||||||||||||||||
Adjusted return on common equity | 13.5% | 2.7% | (0.8)% | (2.0)% | (1.3)% | ||||||||||||||||||||||||||||||
Earnings Per Common Share, Diluted (1), (6) | |||||||||||||||||||||||||||||||||||
Net income (loss) available to shareholders per common share | $4.34 | $0.11 | $(6.96) | $(11.69) | $(32.49) | ||||||||||||||||||||||||||||||
Adjusted earnings per common share | $5.41 | $5.05 | $4.36 | $2.10 | $(7.43) | ||||||||||||||||||||||||||||||
Adjusted earnings, less notable items per common share | $6.17 | $5.32 | $4.86 | $3.03 | $4.19 | ||||||||||||||||||||||||||||||
Weighted average common shares outstanding | 83,244,987 | 86,065,150 | 88,124,035 | 89,890,162 | 92,693,188 | ||||||||||||||||||||||||||||||
Book Value Per Common Share | |||||||||||||||||||||||||||||||||||
Book value per common share (1) | $181.23 | $175.19 | $157.26 | $188.90 | $191.58 | ||||||||||||||||||||||||||||||
Book value per common share, excluding AOCI (1) | $128.24 | $120.62 | $118.24 | $124.10 | $132.55 | ||||||||||||||||||||||||||||||
Ending common shares outstanding | 80,952,682 | 84,223,669 | 86,841,260 | 88,211,618 | 91,158,927 | ||||||||||||||||||||||||||||||
(1) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | |||||||||||||||||||||||||||||||||||
(2) See additional information regarding notable items on page 18. | |||||||||||||||||||||||||||||||||||
(3) Includes functional department expenses, public company expenses, certain investment expenses, retirement funding and incentive compensation; and excludes establishment costs. | |||||||||||||||||||||||||||||||||||
(4) Reflects preliminary statutory results as of or for the three months ended September 30, 2021. See additional information on page 22. | |||||||||||||||||||||||||||||||||||
(5) The RBC ratio is reported as a preliminary range on the quarters. | |||||||||||||||||||||||||||||||||||
(6) For loss periods, dilutive shares were not included in the calculation of net income (loss) available to shareholders per common share or adjusted earnings per common share as inclusion of such shares would have an anti-dilutive effect. |
Financial Supplement | 2 |
GAAP Statements of Operations (Unaudited, in millions)
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Revenues | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | September 30, 2021 | September 30, 2020 | |||||||||||||||||||||||||||||||||||||
Premiums | $193 | $162 | $184 | $191 | $184 | $539 | $575 | |||||||||||||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 881 | 919 | 930 | 868 | 882 | 2,730 | 2,595 | |||||||||||||||||||||||||||||||||||||
Net investment income | 1,281 | 1,212 | 1,187 | 1,037 | 996 | 3,680 | 2,564 | |||||||||||||||||||||||||||||||||||||
Other revenues | 117 | 101 | 127 | 119 | 99 | 345 | 294 | |||||||||||||||||||||||||||||||||||||
Revenues before NIGL and NDGL | 2,472 | 2,394 | 2,428 | 2,215 | 2,161 | 7,294 | 6,028 | |||||||||||||||||||||||||||||||||||||
Net investment gains (losses) | (16) | (34) | 14 | 326 | 5 | (36) | (48) | |||||||||||||||||||||||||||||||||||||
Net derivative gains (losses) | 56 | (684) | (1,504) | (2,410) | (1,857) | (2,132) | 2,392 | |||||||||||||||||||||||||||||||||||||
Total revenues | $2,512 | $1,676 | $938 | $131 | $309 | $5,126 | $8,372 | |||||||||||||||||||||||||||||||||||||
Expenses | ||||||||||||||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $413 | $287 | $297 | $276 | $281 | $997 | $816 | |||||||||||||||||||||||||||||||||||||
Policyholder benefits and claims | 1,112 | 752 | 756 | 638 | 3,047 | 2,620 | 5,073 | |||||||||||||||||||||||||||||||||||||
Amortization of DAC and VOBA | (82) | 8 | 91 | (156) | 244 | 17 | 922 | |||||||||||||||||||||||||||||||||||||
Interest expense on debt | 41 | 40 | 41 | 45 | 47 | 122 | 139 | |||||||||||||||||||||||||||||||||||||
Other expenses | 538 | 568 | 521 | 634 | 533 | 1,627 | 1,535 | |||||||||||||||||||||||||||||||||||||
Total expenses | 2,022 | 1,655 | 1,706 | 1,437 | 4,152 | 5,383 | 8,485 | |||||||||||||||||||||||||||||||||||||
Income (loss) before provision for income tax | 490 | 21 | (768) | (1,306) | (3,843) | (257) | (113) | |||||||||||||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 105 | (10) | (185) | (275) | (850) | (90) | (88) | |||||||||||||||||||||||||||||||||||||
Net income (loss) | 385 | 31 | (583) | (1,031) | (2,993) | (167) | (25) | |||||||||||||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests | 2 | — | 2 | 1 | 2 | 4 | 4 | |||||||||||||||||||||||||||||||||||||
Net income (loss) attributable to Brighthouse Financial, Inc. | 383 | 31 | (585) | (1,032) | (2,995) | (171) | (29) | |||||||||||||||||||||||||||||||||||||
Less: Preferred stock dividends | 22 | 21 | 25 | 13 | 17 | 68 | 31 | |||||||||||||||||||||||||||||||||||||
Net income (loss) available to Brighthouse Financial, Inc.’s common shareholders | $361 | $10 | $(610) | $(1,045) | $(3,012) | $(239) | $(60) |
Financial Supplement | 3 |
GAAP Balance Sheets (Unaudited, in millions)
As of | ||||||||||||||||||||||||||||||||
ASSETS | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Investments: | ||||||||||||||||||||||||||||||||
Fixed maturity securities available-for-sale | $87,074 | $84,785 | $78,971 | $82,495 | $79,338 | |||||||||||||||||||||||||||
Equity securities | 90 | 91 | 106 | 138 | 117 | |||||||||||||||||||||||||||
Mortgage loans | 18,267 | 16,732 | 15,690 | 15,808 | 15,746 | |||||||||||||||||||||||||||
Policy loans | 1,264 | 1,255 | 1,245 | 1,291 | 1,289 | |||||||||||||||||||||||||||
Limited partnerships and limited liability companies | 3,959 | 3,546 | 3,219 | 2,810 | 2,562 | |||||||||||||||||||||||||||
Short-term investments | 1,892 | 1,293 | 1,673 | 3,242 | 4,239 | |||||||||||||||||||||||||||
Other invested assets | 2,774 | 2,863 | 2,267 | 3,747 | 5,038 | |||||||||||||||||||||||||||
Total investments | 115,320 | 110,565 | 103,171 | 109,531 | 108,329 | |||||||||||||||||||||||||||
Cash and cash equivalents | 4,108 | 4,882 | 4,025 | 4,108 | 6,189 | |||||||||||||||||||||||||||
Accrued investment income | 764 | 827 | 734 | 676 | 781 | |||||||||||||||||||||||||||
Reinsurance recoverables | 15,339 | 15,290 | 15,257 | 15,338 | 15,052 | |||||||||||||||||||||||||||
Premiums and other receivables | 959 | 837 | 872 | 820 | 1,035 | |||||||||||||||||||||||||||
DAC and VOBA | 5,356 | 5,122 | 5,148 | 4,911 | 4,664 | |||||||||||||||||||||||||||
Other assets | 484 | 494 | 506 | 516 | 447 | |||||||||||||||||||||||||||
Separate account assets | 112,361 | 115,839 | 112,224 | 111,969 | 103,184 | |||||||||||||||||||||||||||
Total assets | $254,691 | $253,856 | $241,937 | $247,869 | $239,681 | |||||||||||||||||||||||||||
LIABILITIES AND EQUITY | ||||||||||||||||||||||||||||||||
Liabilities | ||||||||||||||||||||||||||||||||
Future policy benefits | $43,795 | $43,427 | $42,426 | $44,448 | $44,537 | |||||||||||||||||||||||||||
Policyholder account balances | 63,748 | 60,300 | 55,152 | 54,508 | 52,798 | |||||||||||||||||||||||||||
Other policy-related balances | 3,406 | 3,356 | 3,355 | 3,411 | 3,088 | |||||||||||||||||||||||||||
Payables for collateral under securities loaned and other transactions | 5,639 | 5,143 | 4,281 | 5,252 | 6,989 | |||||||||||||||||||||||||||
Long-term debt | 3,436 | 3,436 | 3,435 | 3,436 | 3,979 | |||||||||||||||||||||||||||
Current income tax payable | 148 | 150 | 152 | 126 | 72 | |||||||||||||||||||||||||||
Deferred income tax liability | 1,120 | 1,109 | 812 | 1,620 | 1,816 | |||||||||||||||||||||||||||
Other liabilities | 4,942 | 4,916 | 5,018 | 5,011 | 4,887 | |||||||||||||||||||||||||||
Separate account liabilities | 112,361 | 115,839 | 112,224 | 111,969 | 103,184 | |||||||||||||||||||||||||||
Total liabilities | 238,595 | 237,676 | 226,855 | 229,781 | 221,350 | |||||||||||||||||||||||||||
Equity | ||||||||||||||||||||||||||||||||
Preferred stock, at par value | — | — | — | — | — | |||||||||||||||||||||||||||
Common stock, at par value | 1 | 1 | 1 | 1 | 1 | |||||||||||||||||||||||||||
Additional paid-in capital | 13,830 | 13,842 | 13,858 | 13,878 | 13,314 | |||||||||||||||||||||||||||
Retained earnings (deficit) | (705) | (1,088) | (1,119) | (534) | 511 | |||||||||||||||||||||||||||
Treasury stock | (1,385) | (1,236) | (1,112) | (1,038) | (941) | |||||||||||||||||||||||||||
Accumulated other comprehensive income (loss) | 4,290 | 4,596 | 3,389 | 5,716 | 5,381 | |||||||||||||||||||||||||||
Total Brighthouse Financial, Inc.’s stockholders’ equity | 16,031 | 16,115 | 15,017 | 18,023 | 18,266 | |||||||||||||||||||||||||||
Noncontrolling interests | 65 | 65 | 65 | 65 | 65 | |||||||||||||||||||||||||||
Total equity | 16,096 | 16,180 | 15,082 | 18,088 | 18,331 | |||||||||||||||||||||||||||
Total liabilities and equity | $254,691 | $253,856 | $241,937 | $247,869 | $239,681 |
Earnings and Select
Metrics from
Business Segments and Corporate & Other
Financial Supplement | 5 |
Statements of Adjusted Earnings by Segment and Corporate & Other (Unaudited, in millions)
For the Three Months Ended September 30, 2021 | ||||||||||||||||||||||||||||||||
Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
Premiums | $49 | $122 | $3 | $19 | $193 | |||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 631 | 32 | 156 | — | 819 | |||||||||||||||||||||||||||
Net investment income | 567 | 183 | 505 | 32 | 1,287 | |||||||||||||||||||||||||||
Other revenues | 104 | 8 | 6 | — | 118 | |||||||||||||||||||||||||||
Total adjusted revenues | $1,351 | $345 | $670 | $51 | $2,417 | |||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $302 | $25 | $77 | $8 | $412 | |||||||||||||||||||||||||||
Policyholder benefits and claims | 267 | 179 | 506 | 19 | 971 | |||||||||||||||||||||||||||
Amortization of DAC and VOBA | (114) | (34) | — | 2 | (146) | |||||||||||||||||||||||||||
Interest expense on debt | — | — | — | 41 | 41 | |||||||||||||||||||||||||||
Other operating costs | 415 | 34 | 45 | 44 | 538 | |||||||||||||||||||||||||||
Total adjusted expenses | 870 | 204 | 628 | 114 | 1,816 | |||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | 481 | 141 | 42 | (63) | 601 | |||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 96 | 31 | 4 | (4) | 127 | |||||||||||||||||||||||||||
Adjusted earnings after provision for income tax | 385 | 110 | 38 | (59) | 474 | |||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests and preferred stock dividends | — | — | — | 24 | 24 | |||||||||||||||||||||||||||
Adjusted earnings | $385 | $110 | $38 | $(83) | $450 | |||||||||||||||||||||||||||
For the Three Months Ended September 30, 2020 | ||||||||||||||||||||||||||||||||
Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
Premiums | $34 | $129 | $— | $21 | $184 | |||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 569 | 83 | 163 | — | 815 | |||||||||||||||||||||||||||
Net investment income | 469 | 131 | 383 | 18 | 1,001 | |||||||||||||||||||||||||||
Other revenues | 85 | 7 | 7 | — | 99 | |||||||||||||||||||||||||||
Total adjusted revenues | $1,157 | $350 | $553 | $39 | $2,099 | |||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $169 | $27 | $82 | $1 | $279 | |||||||||||||||||||||||||||
Policyholder benefits and claims | 9 | 132 | 1,870 | 10 | 2,021 | |||||||||||||||||||||||||||
Amortization of DAC and VOBA | 127 | 50 | — | (19) | 158 | |||||||||||||||||||||||||||
Interest expense on debt | — | — | — | 47 | 47 | |||||||||||||||||||||||||||
Other operating costs | 373 | 47 | 44 | 32 | 496 | |||||||||||||||||||||||||||
Total adjusted expenses | 678 | 256 | 1,996 | 71 | 3,001 | |||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | 479 | 94 | (1,443) | (32) | (902) | |||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 92 | 18 | (304) | (38) | (232) | |||||||||||||||||||||||||||
Adjusted earnings after provision for income tax | 387 | 76 | (1,139) | 6 | (670) | |||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests and preferred stock dividends | — | — | — | 19 | 19 | |||||||||||||||||||||||||||
Adjusted earnings | $387 | $76 | $(1,139) | $(13) | $(689) |
Financial Supplement | 6 |
Statements of Adjusted Earnings by Segment and Corporate & Other (Cont.) (Unaudited, in millions)
For the Nine Months Ended September 30, 2021 | ||||||||||||||||||||||||||||||||
Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
Premiums | $103 | $374 | $3 | $59 | $539 | |||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 1,852 | 221 | 470 | — | 2,543 | |||||||||||||||||||||||||||
Net investment income | 1,650 | 517 | 1,466 | 63 | 3,696 | |||||||||||||||||||||||||||
Other revenues | 301 | 26 | 21 | — | 348 | |||||||||||||||||||||||||||
Total adjusted revenues | $3,906 | $1,138 | $1,960 | $122 | $7,126 | |||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $669 | $80 | $234 | $11 | $994 | |||||||||||||||||||||||||||
Policyholder benefits and claims | 558 | 633 | 1,324 | 52 | 2,567 | |||||||||||||||||||||||||||
Amortization of DAC and VOBA | 136 | 21 | — | 8 | 165 | |||||||||||||||||||||||||||
Interest expense on debt | — | — | — | 122 | 122 | |||||||||||||||||||||||||||
Other operating costs | 1,231 | 126 | 135 | 135 | 1,627 | |||||||||||||||||||||||||||
Total adjusted expenses | 2,594 | 860 | 1,693 | 328 | 5,475 | |||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | 1,312 | 278 | 267 | (206) | 1,651 | |||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 253 | 58 | 31 | (33) | 309 | |||||||||||||||||||||||||||
Adjusted earnings after provision for income tax | 1,059 | 220 | 236 | (173) | 1,342 | |||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests and preferred stock dividends | — | — | — | 72 | 72 | |||||||||||||||||||||||||||
Adjusted earnings | $1,059 | $220 | $236 | $(245) | $1,270 | |||||||||||||||||||||||||||
For the Nine Months Ended September 30, 2020 | ||||||||||||||||||||||||||||||||
Adjusted revenues | Annuities | Life | Run-off | Corporate & Other | Total | |||||||||||||||||||||||||||
Premiums | $109 | $402 | $— | $64 | $575 | |||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 1,662 | 253 | 484 | — | 2,399 | |||||||||||||||||||||||||||
Net investment income | 1,334 | 316 | 873 | 54 | 2,577 | |||||||||||||||||||||||||||
Other revenues | 255 | 18 | 21 | — | 294 | |||||||||||||||||||||||||||
Total adjusted revenues | $3,360 | $989 | $1,378 | $118 | $5,845 | |||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $486 | $79 | $247 | $2 | $814 | |||||||||||||||||||||||||||
Policyholder benefits and claims | 377 | 517 | 2,673 | 41 | 3,608 | |||||||||||||||||||||||||||
Amortization of DAC and VOBA | 322 | 104 | — | (12) | 414 | |||||||||||||||||||||||||||
Interest expense on debt | — | — | — | 139 | 139 | |||||||||||||||||||||||||||
Other operating costs | 1,102 | 122 | 137 | 137 | 1,498 | |||||||||||||||||||||||||||
Total adjusted expenses | 2,287 | 822 | 3,057 | 307 | 6,473 | |||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | 1,073 | 167 | (1,679) | (189) | (628) | |||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 199 | 32 | (355) | (72) | (196) | |||||||||||||||||||||||||||
Adjusted earnings after provision for income tax | 874 | 135 | (1,324) | (117) | (432) | |||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests and preferred stock dividends | — | — | — | 35 | 35 | |||||||||||||||||||||||||||
Adjusted earnings | $874 | $135 | $(1,324) | $(152) | $(467) |
Financial Supplement | 7 |
Annuities — Statements of Adjusted Earnings (Unaudited, in millions)
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Adjusted revenues | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | September 30, 2021 | September 30, 2020 | |||||||||||||||||||||||||||||||||||||
Premiums | $49 | $18 | $36 | $38 | $34 | $103 | $109 | |||||||||||||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 631 | 618 | 603 | 588 | 569 | 1,852 | 1,662 | |||||||||||||||||||||||||||||||||||||
Net investment income | 567 | 533 | 550 | 486 | 469 | 1,650 | 1,334 | |||||||||||||||||||||||||||||||||||||
Other revenues | 104 | 88 | 109 | 91 | 85 | 301 | 255 | |||||||||||||||||||||||||||||||||||||
Total adjusted revenues | $1,351 | $1,257 | $1,298 | $1,203 | $1,157 | $3,906 | $3,360 | |||||||||||||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $302 | $182 | $185 | $165 | $169 | $669 | $486 | |||||||||||||||||||||||||||||||||||||
Policyholder benefits and claims | 267 | 118 | 173 | 153 | 9 | 558 | 377 | |||||||||||||||||||||||||||||||||||||
Amortization of DAC and VOBA | (114) | 123 | 127 | 118 | 127 | 136 | 322 | |||||||||||||||||||||||||||||||||||||
Interest expense on debt | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Other operating costs | 415 | 417 | 399 | 407 | 373 | 1,231 | 1,102 | |||||||||||||||||||||||||||||||||||||
Total adjusted expenses | 870 | 840 | 884 | 843 | 678 | 2,594 | 2,287 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | 481 | 417 | 414 | 360 | 479 | 1,312 | 1,073 | |||||||||||||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 96 | 79 | 78 | 67 | 92 | 253 | 199 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings | $385 | $338 | $336 | $293 | $387 | $1,059 | $874 |
Financial Supplement | 8 |
Annuities — Select Operating Metrics (Unaudited, in millions)
For the Three Months Ended | ||||||||||||||||||||||||||||||||
VARIABLE AND SHIELD LEVEL ANNUITIES ACCOUNT VALUE (1) | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Account value, beginning of period | $130,017 | $125,527 | $124,227 | $115,111 | $110,993 | |||||||||||||||||||||||||||
Deposits | 2,201 | 2,173 | 1,972 | 1,838 | 1,428 | |||||||||||||||||||||||||||
Withdrawals, surrenders and contract benefits | (2,776) | (2,874) | (2,748) | (2,593) | (1,958) | |||||||||||||||||||||||||||
Net flows (2) | (575) | (701) | (776) | (755) | (530) | |||||||||||||||||||||||||||
Investment performance (3) | (426) | 6,026 | 2,869 | 10,663 | 5,404 | |||||||||||||||||||||||||||
Policy charges and other | (754) | (835) | (793) | (792) | (756) | |||||||||||||||||||||||||||
Account value, end of period | $128,262 | $130,017 | $125,527 | $124,227 | $115,111 | |||||||||||||||||||||||||||
FIXED ANNUITIES ACCOUNT VALUE (4) | ||||||||||||||||||||||||||||||||
Account value, beginning of period | $15,456 | $15,404 | $15,358 | $14,443 | $13,660 | |||||||||||||||||||||||||||
Deposits | 222 | 197 | 231 | 1,159 | 946 | |||||||||||||||||||||||||||
Withdrawals, surrenders and contract benefits | (234) | (231) | (279) | (332) | (242) | |||||||||||||||||||||||||||
Net flows (2) | (12) | (34) | (48) | 827 | 704 | |||||||||||||||||||||||||||
Interest credited | 99 | 98 | 107 | 89 | 98 | |||||||||||||||||||||||||||
Other | (7) | (12) | (13) | (1) | (19) | |||||||||||||||||||||||||||
Account value, end of period | $15,536 | $15,456 | $15,404 | $15,358 | $14,443 | |||||||||||||||||||||||||||
INCOME ANNUITIES (1) | ||||||||||||||||||||||||||||||||
Income annuity insurance liabilities | $4,642 | $4,665 | $4,624 | $4,817 | $4,798 | |||||||||||||||||||||||||||
(1) Includes general account and separate account. | ||||||||||||||||||||||||||||||||
(2) Deposits and withdrawals include policy exchanges. | ||||||||||||||||||||||||||||||||
(3) Includes imputed interest on indexed annuities and the interest credited on the general account investment option of variable products. | ||||||||||||||||||||||||||||||||
(4) Includes fixed index annuities. |
Financial Supplement | 9 |
Annuities — Select Operating Metrics (Cont.) (Unaudited, in millions)
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
VARIABLE AND SHIELD LEVEL ANNUITY SALES | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | September 30, 2021 | September 30, 2020 | |||||||||||||||||||||||||||||||||||||
Shield Level Annuities (1) | $1,634 | $1,593 | $1,423 | $1,359 | $934 | $4,650 | $2,979 | |||||||||||||||||||||||||||||||||||||
GMWB/GMAB | 396 | 393 | 366 | 332 | 350 | 1,155 | 949 | |||||||||||||||||||||||||||||||||||||
GMDB only | 97 | 100 | 95 | 81 | 87 | 292 | 256 | |||||||||||||||||||||||||||||||||||||
GMIB | 17 | 18 | 23 | 23 | 19 | 58 | 60 | |||||||||||||||||||||||||||||||||||||
Total variable and Shield Level annuity sales | $2,144 | $2,104 | $1,907 | $1,795 | $1,390 | $6,155 | $4,244 | |||||||||||||||||||||||||||||||||||||
FIXED AND INCOME ANNUITY SALES | ||||||||||||||||||||||||||||||||||||||||||||
Fixed index annuities (2) | $198 | $173 | $182 | $253 | $234 | $553 | $751 | |||||||||||||||||||||||||||||||||||||
Fixed deferred annuities | 19 | 22 | 42 | 902 | 709 | 83 | 1,139 | |||||||||||||||||||||||||||||||||||||
Single premium immediate annuities | — | — | 1 | — | 1 | 1 | 6 | |||||||||||||||||||||||||||||||||||||
Other fixed and income annuities | 1 | — | — | 1 | 1 | 1 | 2 | |||||||||||||||||||||||||||||||||||||
Total fixed and income annuity sales | $218 | $195 | $225 | $1,156 | $945 | $638 | $1,898 | |||||||||||||||||||||||||||||||||||||
(1) Shield Level Annuities refers to our suite of structured annuities consisting of products marketed under various names. | ||||||||||||||||||||||||||||||||||||||||||||
(2) Represents 100% of gross sales on directly written business and the proportion of assumed gross sales under reinsurance agreements. |
Financial Supplement | 10 |
Life — Statements of Adjusted Earnings (Unaudited, in millions)
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Adjusted revenues | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | September 30, 2021 | September 30, 2020 | |||||||||||||||||||||||||||||||||||||
Premiums | $122 | $125 | $127 | $131 | $129 | $374 | $402 | |||||||||||||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 32 | 83 | 106 | 62 | 83 | 221 | 253 | |||||||||||||||||||||||||||||||||||||
Net investment income | 183 | 168 | 166 | 144 | 131 | 517 | 316 | |||||||||||||||||||||||||||||||||||||
Other revenues | 8 | 7 | 11 | 8 | 7 | 26 | 18 | |||||||||||||||||||||||||||||||||||||
Total adjusted revenues | $345 | $383 | $410 | $345 | $350 | $1,138 | $989 | |||||||||||||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $25 | $24 | $31 | $27 | $27 | $80 | $79 | |||||||||||||||||||||||||||||||||||||
Policyholder benefits and claims | 179 | 216 | 238 | 246 | 132 | 633 | 517 | |||||||||||||||||||||||||||||||||||||
Amortization of DAC and VOBA | (34) | 10 | 45 | 3 | 50 | 21 | 104 | |||||||||||||||||||||||||||||||||||||
Interest expense on debt | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Other operating costs | 34 | 48 | 44 | 54 | 47 | 126 | 122 | |||||||||||||||||||||||||||||||||||||
Total adjusted expenses | 204 | 298 | 358 | 330 | 256 | 860 | 822 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | 141 | 85 | 52 | 15 | 94 | 278 | 167 | |||||||||||||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 31 | 17 | 10 | 2 | 18 | 58 | 32 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings | $110 | $68 | $42 | $13 | $76 | $220 | $135 |
Financial Supplement | 11 |
Life — Select Operating Metrics (Unaudited, in millions)
For the Three Months Ended | ||||||||||||||||||||||||||||||||
LIFE ACCOUNT VALUE: GENERAL ACCOUNT | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Universal and variable universal life account value, beginning of period | $2,667 | $2,670 | $2,674 | $2,670 | $2,674 | |||||||||||||||||||||||||||
Premiums and deposits (1) | 75 | 78 | 74 | 69 | 65 | |||||||||||||||||||||||||||
Surrenders and contract benefits | (40) | (39) | (46) | (43) | (38) | |||||||||||||||||||||||||||
Net flows | 35 | 39 | 28 | 26 | 27 | |||||||||||||||||||||||||||
Net transfers from (to) separate account | 28 | 9 | 8 | 25 | 16 | |||||||||||||||||||||||||||
Interest credited | 26 | 25 | 28 | 26 | 26 | |||||||||||||||||||||||||||
Policy charges and other | (76) | (76) | (68) | (73) | (73) | |||||||||||||||||||||||||||
Universal and variable universal life account value, end of period | $2,680 | $2,667 | $2,670 | $2,674 | $2,670 | |||||||||||||||||||||||||||
LIFE ACCOUNT VALUE: SEPARATE ACCOUNT | ||||||||||||||||||||||||||||||||
Variable universal life account value, beginning of period | $6,721 | $6,373 | $6,230 | $5,582 | $5,261 | |||||||||||||||||||||||||||
Premiums and deposits | 46 | 47 | 49 | 50 | 50 | |||||||||||||||||||||||||||
Surrenders and contract benefits | (52) | (64) | (81) | (54) | (49) | |||||||||||||||||||||||||||
Net flows | (6) | (17) | (32) | (4) | 1 | |||||||||||||||||||||||||||
Investment performance | (31) | 423 | 237 | 733 | 390 | |||||||||||||||||||||||||||
Net transfers from (to) general account | (28) | (9) | (8) | (25) | (16) | |||||||||||||||||||||||||||
Policy charges and other | (58) | (49) | (54) | (56) | (54) | |||||||||||||||||||||||||||
Variable universal life account value, end of period | $6,598 | $6,721 | $6,373 | $6,230 | $5,582 | |||||||||||||||||||||||||||
(1) Includes premiums and sales directed to the general account investment option of variable products. |
Financial Supplement | 12 |
Life — Select Operating Metrics (Cont.) (Unaudited, in millions)
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
LIFE SALES | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | September 30, 2021 | September 30, 2020 | |||||||||||||||||||||||||||||||||||||
Total life sales | $27 | $26 | $23 | $15 | $13 | $76 | $41 |
As of | ||||||||||||||||||||||||||||||||
LIFE INSURANCE IN-FORCE | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Whole Life | ||||||||||||||||||||||||||||||||
Life Insurance in-force, before reinsurance | $19,028 | $19,223 | $19,390 | $19,585 | $19,762 | |||||||||||||||||||||||||||
Life Insurance in-force, net of reinsurance | $3,239 | $3,265 | $3,332 | $3,313 | $3,371 | |||||||||||||||||||||||||||
Term Life | ||||||||||||||||||||||||||||||||
Life Insurance in-force, before reinsurance | $379,193 | $382,200 | $385,396 | $388,298 | $391,583 | |||||||||||||||||||||||||||
Life Insurance in-force, net of reinsurance | $298,363 | $299,414 | $300,658 | $301,731 | $303,232 | |||||||||||||||||||||||||||
Universal and Variable Universal Life | ||||||||||||||||||||||||||||||||
Life Insurance in-force, before reinsurance | $49,575 | $50,147 | $50,397 | $50,922 | $52,377 | |||||||||||||||||||||||||||
Life Insurance in-force, net of reinsurance | $37,314 | $37,611 | $37,641 | $38,490 | $39,258 | |||||||||||||||||||||||||||
Financial Supplement | 13 |
Run-off — Statements of Adjusted Earnings (Unaudited, in millions)
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Adjusted revenues | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | September 30, 2021 | September 30, 2020 | |||||||||||||||||||||||||||||||||||||
Premiums | $3 | $— | $— | $2 | $— | $3 | $— | |||||||||||||||||||||||||||||||||||||
Universal life and investment-type product policy fees | 156 | 155 | 159 | 155 | 163 | 470 | 484 | |||||||||||||||||||||||||||||||||||||
Net investment income | 505 | 499 | 462 | 396 | 383 | 1,466 | 873 | |||||||||||||||||||||||||||||||||||||
Other revenues | 6 | 8 | 7 | 7 | 7 | 21 | 21 | |||||||||||||||||||||||||||||||||||||
Total adjusted revenues | $670 | $662 | $628 | $560 | $553 | $1,960 | $1,378 | |||||||||||||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $77 | $77 | $80 | $82 | $82 | $234 | $247 | |||||||||||||||||||||||||||||||||||||
Policyholder benefits and claims | 506 | 399 | 419 | 405 | 1,870 | 1,324 | 2,673 | |||||||||||||||||||||||||||||||||||||
Amortization of DAC and VOBA | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Interest expense on debt | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Other operating costs | 45 | 46 | 44 | 49 | 44 | 135 | 137 | |||||||||||||||||||||||||||||||||||||
Total adjusted expenses | 628 | 522 | 543 | 536 | 1,996 | 1,693 | 3,057 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | 42 | 140 | 85 | 24 | (1,443) | 267 | (1,679) | |||||||||||||||||||||||||||||||||||||
Provision for income tax expense (benefit) | 4 | 18 | 9 | (1) | (304) | 31 | (355) | |||||||||||||||||||||||||||||||||||||
Adjusted earnings | $38 | $122 | $76 | $25 | $(1,139) | $236 | $(1,324) |
Financial Supplement | 14 |
Run-off — Select Operating Metrics (Unaudited, in millions)
For the Three Months Ended | ||||||||||||||||||||||||||||||||
UNIVERSAL LIFE WITH SECONDARY GUARANTEES ACCOUNT VALUE | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Account value, beginning of period | $5,683 | $5,740 | $5,823 | $5,865 | $5,930 | |||||||||||||||||||||||||||
Premiums and deposits (1) | 167 | 174 | 175 | 181 | 176 | |||||||||||||||||||||||||||
Surrenders and contract benefits | (20) | (27) | (49) | (23) | (40) | |||||||||||||||||||||||||||
Net flows | 147 | 147 | 126 | 158 | 136 | |||||||||||||||||||||||||||
Interest credited | 48 | 50 | 49 | 51 | 51 | |||||||||||||||||||||||||||
Policy charges and other | (249) | (254) | (258) | (251) | (252) | |||||||||||||||||||||||||||
Account value, end of period | $5,629 | $5,683 | $5,740 | $5,823 | $5,865 |
As of | ||||||||||||||||||||||||||||||||
LIFE INSURANCE IN-FORCE | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Universal Life with Secondary Guarantees | ||||||||||||||||||||||||||||||||
Life Insurance in-force, before reinsurance | $75,020 | $75,487 | $76,050 | $76,745 | $76,342 | |||||||||||||||||||||||||||
Life Insurance in-force, net of reinsurance | $37,000 | $37,133 | $36,690 | $37,044 | $36,842 | |||||||||||||||||||||||||||
(1) Includes premiums and sales directed to the general account investment option of variable products. |
Financial Supplement | 15 |
Corporate & Other — Statements of Adjusted Earnings (Unaudited, in millions)
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
Adjusted revenues | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | September 30, 2021 | September 30, 2020 | |||||||||||||||||||||||||||||||||||||
Premiums | $19 | $19 | $21 | $20 | $21 | $59 | $64 | |||||||||||||||||||||||||||||||||||||
Universal life and investment-type product policy fees | — | — | — | — | — | — | — | |||||||||||||||||||||||||||||||||||||
Net investment income | 32 | 17 | 14 | 16 | 18 | 63 | 54 | |||||||||||||||||||||||||||||||||||||
Other revenues | — | — | — | 2 | — | — | — | |||||||||||||||||||||||||||||||||||||
Total adjusted revenues | $51 | $36 | $35 | $38 | $39 | $122 | $118 | |||||||||||||||||||||||||||||||||||||
Adjusted expenses | ||||||||||||||||||||||||||||||||||||||||||||
Interest credited to policyholder account balances | $8 | $3 | $— | $1 | $1 | $11 | $2 | |||||||||||||||||||||||||||||||||||||
Policyholder benefits and claims | 19 | 15 | 18 | 16 | 10 | 52 | 41 | |||||||||||||||||||||||||||||||||||||
Amortization of DAC and VOBA | 2 | 3 | 3 | 3 | (19) | 8 | (12) | |||||||||||||||||||||||||||||||||||||
Interest expense on debt | 41 | 40 | 41 | 45 | 47 | 122 | 139 | |||||||||||||||||||||||||||||||||||||
Other operating costs | 44 | 57 | 34 | 116 | 32 | 135 | 137 | |||||||||||||||||||||||||||||||||||||
Total adjusted expenses | 114 | 118 | 96 | 181 | 71 | 328 | 307 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings before provision for income tax | (63) | (82) | (61) | (143) | (32) | (206) | (189) | |||||||||||||||||||||||||||||||||||||
Provision for income tax expense (benefit) | (4) | (10) | (19) | (15) | (38) | (33) | (72) | |||||||||||||||||||||||||||||||||||||
Adjusted earnings after provision for income tax | (59) | (72) | (42) | (128) | 6 | (173) | (117) | |||||||||||||||||||||||||||||||||||||
Less: Net income (loss) attributable to noncontrolling interests and preferred stock dividends | 24 | 21 | 27 | 14 | 19 | 72 | 35 | |||||||||||||||||||||||||||||||||||||
Adjusted earnings | $(83) | $(93) | $(69) | $(142) | $(13) | $(245) | $(152) |
Other
Information
Financial Supplement | 17 |
DAC and VOBA and Net Derivative Gains (Losses) (Unaudited, in millions)
For the Three Months Ended | ||||||||||||||||||||||||||||||||
DAC AND VOBA ROLLFORWARD | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Balance, beginning of period | $5,122 | $5,148 | $4,911 | $4,664 | $4,856 | |||||||||||||||||||||||||||
Capitalization | 126 | 120 | 114 | 128 | 90 | |||||||||||||||||||||||||||
Amortization: | ||||||||||||||||||||||||||||||||
Included in adjusted earnings, excluding notable items | (127) | (136) | (155) | (124) | (121) | |||||||||||||||||||||||||||
Related to notable items, included in adjusted expenses | 273 | — | (20) | — | (37) | |||||||||||||||||||||||||||
Related to items not included in adjusted expenses | (64) | 128 | 84 | 280 | (86) | |||||||||||||||||||||||||||
Total amortization | 82 | (8) | (91) | 156 | (244) | |||||||||||||||||||||||||||
Unrealized investment gains (losses) | 26 | (138) | 214 | (37) | (38) | |||||||||||||||||||||||||||
Balance, end of period | $5,356 | $5,122 | $5,148 | $4,911 | $4,664 | |||||||||||||||||||||||||||
As of | ||||||||||||||||||||||||||||||||
DAC AND VOBA BY SEGMENT AND CORPORATE & OTHER | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Annuities | $4,308 | $4,103 | $4,117 | $3,829 | $3,574 | |||||||||||||||||||||||||||
Life | 946 | 914 | 923 | 971 | 976 | |||||||||||||||||||||||||||
Run-off | 4 | 4 | 5 | 5 | 5 | |||||||||||||||||||||||||||
Corporate & Other | 98 | 101 | 103 | 106 | 109 | |||||||||||||||||||||||||||
Total DAC and VOBA | $5,356 | $5,122 | $5,148 | $4,911 | $4,664 |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
NET DERIVATIVE GAINS (LOSSES) | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Net derivative gains (losses): | ||||||||||||||||||||||||||||||||
Variable annuity hedges and embedded derivatives, net | $(59) | $(1,132) | $(553) | $(2,092) | $(1,688) | |||||||||||||||||||||||||||
ULSG hedges | 19 | 403 | (958) | (291) | (97) | |||||||||||||||||||||||||||
Other hedges and embedded derivatives | 90 | 40 | 2 | (32) | (77) | |||||||||||||||||||||||||||
Subtotal | 50 | (689) | (1,509) | (2,415) | (1,862) | |||||||||||||||||||||||||||
Investment hedge adjustments | 6 | 5 | 5 | 5 | 5 | |||||||||||||||||||||||||||
Total net derivative gains (losses) | $56 | $(684) | $(1,504) | $(2,410) | $(1,857) |
Financial Supplement | 18 |
Notable Items (Unaudited, in millions)
For the Three Months Ended | ||||||||||||||||||||||||||||||||
NOTABLE ITEMS IMPACTING ADJUSTED EARNINGS | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Actuarial items and other insurance adjustments | $44 | $— | $29 | $17 | $1,062 | |||||||||||||||||||||||||||
Establishment costs | 20 | 23 | 14 | 32 | 15 | |||||||||||||||||||||||||||
Debt repayment costs | — | — | — | 34 | — | |||||||||||||||||||||||||||
Total notable items (1) | $64 | $23 | $43 | $83 | $1,077 | |||||||||||||||||||||||||||
NOTABLE ITEMS BY SEGMENT AND CORPORATE & OTHER | ||||||||||||||||||||||||||||||||
Annuities | $(42) | $— | $— | $— | $(102) | |||||||||||||||||||||||||||
Life | (3) | — | — | 17 | 11 | |||||||||||||||||||||||||||
Run-off | 89 | — | 29 | — | 1,172 | |||||||||||||||||||||||||||
Corporate & Other | 20 | 23 | 14 | 66 | (4) | |||||||||||||||||||||||||||
Total notable items (1) | $64 | $23 | $43 | $83 | $1,077 | |||||||||||||||||||||||||||
(1) Notable items reflect the negative (positive) after-tax impact to adjusted earnings of certain unanticipated items and events, as well as certain items and events that were anticipated, such as establishment costs. The presentation of notable items is intended to help investors better understand our results and to evaluate and forecast those results. |
Financial Supplement | 19 |
Variable Annuity Separate Account Returns and Allocations (Unaudited)
For the Three Months Ended | ||||||||||||||||||||||||||||||||
VARIABLE ANNUITY SEPARATE ACCOUNT RETURNS | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Total Quarterly VA separate account gross returns | (0.42)% | 5.91% | 2.93% | 11.48% | 6.04% | |||||||||||||||||||||||||||
TOTAL VARIABLE ANNUITY SEPARATE ACCOUNT ALLOCATIONS | ||||||||||||||||||||||||||||||||
Percent allocated to equity funds | 28.54% | 28.62% | 29.28% | 27.88% | 26.85% | |||||||||||||||||||||||||||
Percent allocated to bond funds/other funds | 8.67% | 8.40% | 8.44% | 8.43% | 8.82% | |||||||||||||||||||||||||||
Percent allocated to target volatility funds | 20.98% | 21.14% | 20.15% | 21.69% | 22.38% | |||||||||||||||||||||||||||
Percent allocated to balanced funds | 41.81% | 41.84% | 42.13% | 42.00% | 41.95% | |||||||||||||||||||||||||||
Financial Supplement | 20 |
Summary of Investments (Unaudited, dollars in millions)
September 30, 2021 | December 31, 2020 | |||||||||||||||||||||||||
Amount | % of Total | Amount | % of Total | |||||||||||||||||||||||
Fixed maturity securities: | ||||||||||||||||||||||||||
U.S. corporate securities | $38,683 | 32.39% | $37,906 | 33.36% | ||||||||||||||||||||||
Foreign corporate securities | 11,694 | 9.79% | 11,511 | 10.13% | ||||||||||||||||||||||
U.S. government and agency securities | 9,480 | 7.94% | 8,638 | 7.60% | ||||||||||||||||||||||
Residential mortgage-backed securities | 9,517 | 7.97% | 8,294 | 7.30% | ||||||||||||||||||||||
Commercial mortgage-backed securities | 7,095 | 5.94% | 6,790 | 5.98% | ||||||||||||||||||||||
State and political subdivision securities | 4,846 | 4.06% | 4,640 | 4.08% | ||||||||||||||||||||||
Asset-backed securities | 3,907 | 3.27% | 2,884 | 2.54% | ||||||||||||||||||||||
Foreign government securities | 1,852 | 1.55% | 1,832 | 1.60% | ||||||||||||||||||||||
Total fixed maturity securities | 87,074 | 72.91% | 82,495 | 72.59% | ||||||||||||||||||||||
Equity securities | 90 | 0.08% | 138 | 0.12% | ||||||||||||||||||||||
Mortgage loans: | ||||||||||||||||||||||||||
Commercial mortgage loans | 11,156 | 9.34% | 9,714 | 8.55% | ||||||||||||||||||||||
Agricultural mortgage loans | 3,997 | 3.35% | 3,538 | 3.11% | ||||||||||||||||||||||
Residential mortgage loans | 3,214 | 2.69% | 2,650 | 2.33% | ||||||||||||||||||||||
Allowance for credit losses | (100) | (0.08)% | (94) | (0.08)% | ||||||||||||||||||||||
Total mortgage loans, net | 18,267 | 15.30% | 15,808 | 13.91% | ||||||||||||||||||||||
Policy loans | 1,264 | 1.06% | 1,291 | 1.14% | ||||||||||||||||||||||
Limited partnerships and limited liability companies | 3,959 | 3.31% | 2,810 | 2.47% | ||||||||||||||||||||||
Cash, cash equivalents and short-term investments | 6,000 | 5.02% | 7,350 | 6.47% | ||||||||||||||||||||||
Other invested assets: | ||||||||||||||||||||||||||
Derivatives: | ||||||||||||||||||||||||||
Interest rate | 745 | 0.62% | 2,094 | 1.84% | ||||||||||||||||||||||
Equity market | 1,485 | 1.24% | 1,227 | 1.08% | ||||||||||||||||||||||
Foreign currency exchange rate | 327 | 0.28% | 220 | 0.19% | ||||||||||||||||||||||
Credit | 39 | 0.03% | 41 | 0.04% | ||||||||||||||||||||||
Total derivatives | 2,596 | 2.17% | 3,582 | 3.15% | ||||||||||||||||||||||
FHLB common stock | 59 | 0.05% | 39 | 0.04% | ||||||||||||||||||||||
Other | 119 | 0.10% | 126 | 0.11% | ||||||||||||||||||||||
Total other invested assets | 2,774 | 2.32% | 3,747 | 3.30% | ||||||||||||||||||||||
Total investments and cash and cash equivalents | $119,428 | 100.00% | $113,639 | 100.00% |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | ||||||||||||||||||||||||||||
Net investment income yield (1), (2) | 5.16% | 5.08% | 5.12% | 4.56% | 4.42% | |||||||||||||||||||||||||||
(1) Yields are calculated on investment income as a percent of average quarterly asset carrying values. Investment income includes investment hedge adjustments, excludes realized gains and losses and reflects the GAAP adjustments described beginning on page A-2 of the Appendix hereto. Asset carrying values exclude unrealized gains (losses), collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties. | ||||||||||||||||||||||||||||||||
(2) Investment fee and expense yields are calculated as investment fees and expenses as a percent of average quarterly asset estimated fair values. Asset estimated fair values exclude collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties. |
Financial Supplement | 21 |
Statutory Statement of Operations Information (Unaudited, in millions except Normalized Statutory Earnings (Loss))
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
COMBINED REVENUES AND EXPENSES (1) | PRELIMINARY September 30, 2021 (2) | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | PRELIMINARY September 30, 2021 (2) | September 30, 2020 | |||||||||||||||||||||||||||||||||||||
Total revenues (Line 9) | $3,900 | $3,540 | $3,551 | $3,503 | $2,904 | $10,991 | $10,065 | |||||||||||||||||||||||||||||||||||||
Total benefits and expenses before dividends to policyholders (Line 28) | $4,100 | $3,758 | $1,824 | $1,445 | $1,351 | $9,682 | $12,995 | |||||||||||||||||||||||||||||||||||||
COMBINED NET INCOME (LOSS) (1) | ||||||||||||||||||||||||||||||||||||||||||||
Gain (loss) from operations net of taxes and dividends to policyholders (Line 33) | $(200) | $(206) | $1,737 | $2,187 | $1,519 | $1,331 | $(2,969) | |||||||||||||||||||||||||||||||||||||
Net realized capital gains (losses), net of taxes and certain transfers to interest maintenance reserve (Line 34) | — | (372) | (812) | (453) | (1,253) | (1,184) | (29) | |||||||||||||||||||||||||||||||||||||
Net income (loss) (Line 35) | $(200) | $(578) | $925 | $1,734 | $266 | $147 | $(2,998) | |||||||||||||||||||||||||||||||||||||
For the Nine Months Ended | ||||||||||||||||||||||||||||||||||||||||||||
NORMALIZED STATUTORY EARNINGS (LOSS) (3), (4) | PRELIMINARY September 30, 2021 (2) | September 30, 2020 | ||||||||||||||||||||||||||||||||||||||||||
(In billions) | ||||||||||||||||||||||||||||||||||||||||||||
Statutory net gain (loss) from operations, pre-tax | $1.5 | $(2.8) | ||||||||||||||||||||||||||||||||||||||||||
Add: net realized capital gains (losses) | (1.4) | (0.1) | ||||||||||||||||||||||||||||||||||||||||||
Add: change in total asset requirement at CTE95, net of the change in VA reserves | (0.4) | 0.2 | ||||||||||||||||||||||||||||||||||||||||||
Add: unrealized gains (losses) on VA hedging program | 0.2 | 2.7 | ||||||||||||||||||||||||||||||||||||||||||
Add: impact of actuarial items and other insurance adjustments | (0.2) | (0.6) | ||||||||||||||||||||||||||||||||||||||||||
Add: other adjustments, net | 0.1 | 0.2 | ||||||||||||||||||||||||||||||||||||||||||
Normalized statutory earnings (loss) | $(0.2) | $(0.4) | ||||||||||||||||||||||||||||||||||||||||||
(1) Combined statutory results are for Brighthouse Life Insurance Company, Brighthouse Life Insurance Company of NY and New England Life Insurance Company. | ||||||||||||||||||||||||||||||||||||||||||||
(2) Reflects preliminary statutory results for the three months and nine months ended September 30, 2021. | ||||||||||||||||||||||||||||||||||||||||||||
(3) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | ||||||||||||||||||||||||||||||||||||||||||||
(4) Normalized statutory earnings (loss), presented in billions, is for Brighthouse Life Insurance Company and New England Life Insurance Company. |
Financial Supplement | 22 |
Statutory Balance Sheet and Surplus Information (Unaudited, in millions)
As of | ||||||||||||||||||||||||||||||||||||||
COMBINED ASSETS, LIABILITIES, AND CAPITAL AND SURPLUS (1) | PRELIMINARY September 30, 2021 (2) | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||||||||
Total assets (Line 28) | $206,100 | $205,018 | $197,181 | $197,847 | $192,215 | |||||||||||||||||||||||||||||||||
Total liabilities (Line 28) | $197,800 | $196,967 | $189,012 | $190,287 | $184,709 | |||||||||||||||||||||||||||||||||
Total capital and surplus (Line 38) | $8,300 | $8,051 | $8,169 | $7,560 | $7,506 | |||||||||||||||||||||||||||||||||
COMBINED TAC AND RBC RATIO (1), (3) | ||||||||||||||||||||||||||||||||||||||
Combined total adjusted capital | $9,700 | $9,432 | $9,421 | $8,617 | $8,432 | |||||||||||||||||||||||||||||||||
Combined risk-based capital ratio (4) | 520%-540% | 480%-500% | 500%-520% | 487% | 525%-545% | |||||||||||||||||||||||||||||||||
As of | ||||||||||||||||||||||||||||||||||||||
COMBINED ORDINARY DIVIDEND CAPACITY (1) | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||||||||
Dividends paid to Holding Company | $— | $250 | $— | $511 | $— | |||||||||||||||||||||||||||||||||
Remaining ordinary dividend capacity (5) | $588 | $588 | $838 | $816 | $1,327 | |||||||||||||||||||||||||||||||||
(1) Combined statutory results are for Brighthouse Life Insurance Company and New England Life Insurance Company. | ||||||||||||||||||||||||||||||||||||||
(2) Reflects preliminary statutory results as of September 30, 2021. | ||||||||||||||||||||||||||||||||||||||
(3) See definitions for Non-GAAP and Other Financial Disclosures in the Appendix beginning on page A-2. | ||||||||||||||||||||||||||||||||||||||
(4) The RBC ratio is reported as a preliminary range on the quarters. | ||||||||||||||||||||||||||||||||||||||
(5) Reflects remaining dividend amounts that may be paid at one or more points in time during the respective calendar year without prior regulatory approval. |
Appendix
Financial Supplement | A-1 |
Note Regarding Forward-Looking Statements
This financial supplement and other oral or written statements that we make from time to time may contain information that includes or is based upon forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve substantial risks and uncertainties. We have tried, wherever possible, to identify such statements using words such as “anticipate,” “estimate,” “expect,” “project,” “may,” “will,” “could,” “intend,” “goal,” “target,” “guidance,” “forecast,” “preliminary,” “objective,” “continue,” “aim,” “plan,” “believe” and other words and terms of similar meaning, or that are tied to future periods, in connection with a discussion of future operating or financial performance. In particular, these include, without limitation, statements relating to future actions, prospective services or products, financial projections, future performance or results of current and anticipated services or products, sales efforts, expenses, the outcome of contingencies such as legal proceedings, as well as trends in operating and financial results.
Any or all forward-looking statements may turn out to be wrong. They can be affected by inaccurate assumptions or by known or unknown risks and uncertainties. Many such factors will be important in determining the actual future results of Brighthouse Financial. These statements are based on current expectations and the current economic environment and involve a number of risks and uncertainties that are difficult to predict. These statements are not guarantees of future performance. Actual results could differ materially from those expressed or implied in the forward-looking statements due to a variety of known and unknown risks, uncertainties and other factors. Although it is not possible to identify all of these risks and factors, they include, among others: differences between actual experience and actuarial assumptions and the effectiveness of our actuarial models; higher risk management costs and exposure to increased market risk due to guarantees within certain of our products; the effectiveness of our variable annuity exposure risk management strategy and the impact of such strategy on volatility in our profitability measures and negative effects on our statutory capital; material differences from actual outcomes compared to the sensitivities calculated under certain scenarios and sensitivities that we may utilize in connection with our variable annuity risk management strategies; the impact of interest rates on our future ULSG policyholder obligations and net income volatility; the impact of the ongoing worldwide COVID-19 pandemic; the potential material adverse effect of changes in accounting standards, practices or policies applicable to us, including changes in the accounting for long-duration contracts; loss of business and other negative impacts resulting from a downgrade or a potential downgrade in our financial strength or credit ratings; the availability of reinsurance and the ability of the counterparties to our reinsurance or indemnification arrangements to perform their obligations thereunder; heightened competition, including with respect to service, product features, scale, price, actual or perceived financial strength, claims-paying ratings, credit ratings, e-business capabilities and name recognition; our ability to market and distribute our products through distribution channels; any failure of third parties to provide services we need, any failure of the practices and procedures of such third parties and any inability to obtain information or assistance we need from third parties; the ability of our subsidiaries to pay dividends to us, and our ability to pay dividends to our shareholders and repurchase our common stock; the adverse impact on liabilities for policyholder claims as a result of extreme mortality events; the impact of adverse capital and credit market conditions, including with respect to our ability to meet liquidity needs and access capital; the impact of economic conditions in the capital markets and the U.S. and global economy, as well as geo-political or catastrophic events, on our investment portfolio, including on realized and unrealized losses and impairments, net investment spread and net investment income; the impact of events that adversely affect issuers, guarantors or collateral relating to our investments or our derivatives counterparties, on impairments, valuation allowances, reserves, net investment income and changes in unrealized gain or loss positions; the impact of changes in regulation and in supervisory and enforcement policies on our insurance business or other operations; the potential material negative tax impact of potential future tax legislation that could make some of our products less attractive to consumers; the effectiveness of our policies and procedures in managing risk; the loss or disclosure of confidential information, damage to our reputation and impairment of our ability to conduct business effectively as a result of any failure in cyber- or other information security systems; whether all or any portion of the tax consequences of our separation from MetLife, Inc. ("MetLife") are not as expected, leading to material additional taxes or material adverse consequences to tax attributes that impact us; the uncertainty of the outcome of any disputes with MetLife over tax-related or other matters and agreements or disagreements regarding MetLife’s or our obligations under our other agreements; and other factors described from time to time in documents that we file with the U.S. Securities and Exchange Commission (the “SEC”).
For the reasons described above, we caution you against relying on any forward-looking statements, which should also be read in conjunction with the other cautionary statements included and the risks, uncertainties and other factors identified in our Annual Report on Form 10-K for the year ended December 31, 2020, particularly in the sections entitled “Risk Factors” and “Quantitative and Qualitative Disclosures About Market Risk,” as well as in our other subsequent filings with the SEC. Further, any forward-looking statement speaks only as of the date on which it is made, and we undertake no obligation to update or revise any forward-looking statement to reflect events or circumstances after the date on which the statement is made or to reflect the occurrence of unanticipated events, except as otherwise may be required by law.
Financial Supplement | A-2 |
Non-GAAP and Other Financial Disclosures
Our definitions of the non-GAAP and other financial measures may differ from those used by other companies.
Non-GAAP Financial Disclosures
We present certain measures of our performance that are not calculated in accordance with GAAP. We believe that these non-GAAP financial measures highlight our results of operations and the underlying profitability drivers of our business, as well as enhance the understanding of our performance by the investor community.
The following non-GAAP financial measures, previously referred to as operating measures, should not be viewed as substitutes for the most directly comparable financial measures calculated in accordance with GAAP:
Non-GAAP financial measures: | Most directly comparable GAAP financial measures: | |||||||||||||
(i) | adjusted earnings | (i) | net income (loss) available to shareholders (1) | |||||||||||
(ii) | adjusted earnings, less notable items | (ii) | net income (loss) available to shareholders (1) | |||||||||||
(iii) | adjusted revenues | (iii) | revenues | |||||||||||
(iv) | adjusted expenses | (iv) | expenses | |||||||||||
(v) | adjusted earnings per common share | (v) | earnings per common share, diluted (1) | |||||||||||
(vi) | adjusted earnings per common share, less notable items | (vi) | earnings per common share, diluted (1) | |||||||||||
(vii) | adjusted return on common equity | (vii) | return on common equity (2) | |||||||||||
(viii) | adjusted return on common equity, less notable items | (viii) | return on common equity (2) | |||||||||||
(ix) | adjusted net investment income | (ix) | net investment income | |||||||||||
__________________ | ||||||||||||||
(1) Brighthouse uses net income (loss) available to shareholders to refer to net income (loss) available to Brighthouse Financial, Inc.’s common shareholders, and earnings per common share, diluted to refer to net income (loss) available to shareholders per common share. | ||||||||||||||
(2) Brighthouse uses return on common equity to refer to return on Brighthouse Financial, Inc.’s common stockholders' equity. |
Reconciliations to the most directly comparable historical GAAP measures are included for those measures which are presented herein. Reconciliations of these non-GAAP financial measures to the most directly comparable GAAP financial measures are not accessible on a forward-looking basis because we believe it is not possible without unreasonable efforts to provide other than a range of net investment gains and losses and net derivative gains and losses, which can fluctuate significantly within or outside the range and from period to period and may have a material impact on net income (loss) available to shareholders.
Adjusted Earnings, Adjusted Revenues and Adjusted Expenses
Adjusted earnings is a financial measure used by management to evaluate performance, allocate resources and facilitate comparisons to industry results. This financial measure, which may be positive or negative, focuses on our primary businesses principally by excluding the impact of market volatility, which could distort trends.
Adjusted earnings reflects adjusted revenues less (i) adjusted expenses, (ii) provision for income tax expense (benefit), (iii) net income (loss) attributable to noncontrolling interests and (iv) preferred stock dividends. Provided below are the adjustments to GAAP revenues and GAAP expenses used to calculate adjusted revenues and adjusted expenses, respectively.
Financial Supplement | A-3 |
Non-GAAP and Other Financial Disclosures (Cont.)
The following are significant items excluded from total revenues in calculating the adjusted revenues component of adjusted earnings:
•Net investment gains (losses);
•Net derivative gains (losses) except earned income and amortization of premium on derivatives that are hedges of investments or that are used to replicate certain investments, but do not qualify for hedge accounting treatment (“Investment Hedge Adjustments”); and
•Certain variable annuity GMIB fees (“GMIB Fees”).
The following are significant items excluded from total expenses in calculating the adjusted expenses component of adjusted earnings:
•Amounts associated with benefits related to GMIBs (“GMIB Costs”);
•Amounts associated with periodic crediting rate adjustments based on the total return of a contractually referenced pool of assets and market value adjustments associated with surrenders or terminations of contracts (“Market Value Adjustments”); and
•Amortization of DAC and VOBA related to (i) net investment gains (losses), (ii) net derivative gains (losses), (iii) GMIB Fees and GMIB Costs and (iv) Market Value Adjustments.
The tax impact of the adjustments discussed above is calculated net of the statutory tax rate, which could differ from our effective tax rate.
Consistent with GAAP guidance for segment reporting, adjusted earnings is also our GAAP measure of segment performance.
Adjusted Earnings per Common Share and Adjusted Return on Common Equity
Adjusted earnings per common share and adjusted return on common equity are measures used by management to evaluate the execution of our business strategy and align such strategy with our shareholders’ interests.
Adjusted earnings per common share is defined as adjusted earnings for the period divided by the weighted average number of fully diluted shares of common stock outstanding for the period. The weighted average common shares outstanding used to calculate adjusted earnings per share will differ from such shares used to calculate diluted net income (loss) available to shareholders per common share when the inclusion of dilutive shares has an anti-dilutive effect for one calculation but not for the other.
Adjusted return on common equity is defined as total annual adjusted earnings on a four quarter trailing basis, divided by the simple average of the most recent five quarters of total Brighthouse Financial, Inc.’s common stockholders’ equity, excluding AOCI.
Adjusted Net Investment Income
We present adjusted net investment income to measure our performance for management purposes, and we believe it enhances the understanding of our investment portfolio results. Adjusted net investment income represents net investment income, including Investment Hedge Adjustments.
Financial Supplement | A-4 |
Non-GAAP and Other Financial Disclosures (Cont.)
Other Financial Disclosures
Corporate Expenses
Corporate expenses includes functional department expenses, public company expenses, certain investment expenses, retirement funding and incentive compensation; and excludes establishment costs.
Notable items
Certain of the non-GAAP measures described above may be presented further adjusted to exclude notable items. Notable items reflect the impact on our results of certain unanticipated items and events, as well as certain items and events that were anticipated, such as establishment costs. The presentation of notable items and non-GAAP measures, less notable items is intended to help investors better understand our results and to evaluate and forecast those results.
Book Value per Common Share and Book Value per Common Share, excluding AOCI
Brighthouse uses the term “book value” to refer to “Brighthouse Financial, Inc.’s common stockholders’ equity, including AOCI.” Book value per common share is defined as ending Brighthouse Financial, Inc.’s common stockholders’ equity, including AOCI, divided by ending common shares outstanding. Book value per common share, excluding AOCI, is defined as ending Brighthouse Financial, Inc.’s common stockholders’ equity, excluding AOCI, divided by ending common shares outstanding.
CTE95
CTE95 is defined as the amount of assets required to satisfy contract holder obligations across market environments in the average of the worst five percent of a set of capital market scenarios over the life of the contracts.
CTE98
CTE98 is defined as the amount of assets required to satisfy contract holder obligations across market environments in the average of the worst two percent of a set of capital market scenarios over the life of the contracts.
Holding Company Liquid Assets
Holding company liquid assets include liquid assets in Brighthouse Financial, Inc., Brighthouse Holdings, LLC, and Brighthouse Services, LLC. Liquid assets are comprised of cash and cash equivalents, short-term investments and publicly-traded securities, excluding assets that are pledged or otherwise committed. Assets pledged or otherwise committed include assets held in trust.
Total Adjusted Capital
Total adjusted capital primarily consists of statutory capital and surplus, as well as the statutory asset valuation reserve. When referred to as “combined,” represents that of our insurance subsidiaries as a whole.
Financial Supplement | A-5 |
Non-GAAP and Other Financial Disclosures (Cont.)
Other Financial Disclosures (cont.)
Sales
Life insurance sales consist of 100 percent of annualized new premium for term life, first-year paid premium for whole life, universal life, and variable universal life, and total paid premium for indexed universal life. We exclude company-sponsored internal exchanges, corporate-owned life insurance, bank-owned life insurance, and private placement variable universal life.
Annuity sales consist of 100 percent of direct statutory premiums, except for fixed index annuity sales distributed through MassMutual that consist of 90 percent of gross sales. Annuity sales exclude certain internal exchanges. These sales statistics do not correspond to revenues under GAAP, but are used as relevant measures of business activity.
Net Investment Income Yield
Similar to adjusted net investment income, we present net investment income yields as a performance measure we believe enhances the understanding of our investment portfolio results. Net investment income yields are calculated on adjusted net investment income as a percent of average quarterly asset carrying values. Asset carrying values exclude unrealized gains (losses), collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties. Investment fee and expense yields are calculated as investment fees and expenses as a percent of average quarterly asset estimated fair values. Asset estimated fair values exclude collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties.
Normalized Statutory Earnings (Loss)
Normalized statutory earnings (loss) is used by management to measure our insurance companies’ ability to pay future distributions and is reflective of whether our hedging program functions as intended. Normalized statutory earnings (loss) is calculated as statutory pre-tax net gain from operations adjusted for the favorable or unfavorable impacts of (i) net realized capital gains (losses), (ii) the change in total asset requirement at CTE95, net of the change in our variable annuity reserves, and (iii) unrealized gains (losses) associated with our variable annuities risk management strategy. Normalized statutory earnings (loss) may be further adjusted for certain unanticipated items that impacted our results in order to help management and investors better understand, evaluate and forecast those results.
Risk-Based Capital Ratio
The risk-based capital ratio is a method of measuring an insurance company’s capital, taking into consideration its relative size and risk profile, in order to ensure compliance with minimum regulatory capital requirements set by the National Association of Insurance Commissioners. When referred to as “combined,” represents that of our insurance subsidiaries as a whole. The reporting of our combined risk-based capital ratio is not intended for the purpose of ranking any insurance company or for use in connection with any marketing, advertising or promotional activities.
Financial Supplement | A-6 |
Acronyms
AOCI | Accumulated other comprehensive income (loss) | ||||
CTE | Conditional tail expectations | ||||
DAC | Deferred policy acquisition costs | ||||
FHLB | Federal Home Loan Bank | ||||
GAAP | Accounting principles generally accepted in the United States of America | ||||
GMAB | Guaranteed minimum accumulation benefits | ||||
GMDB | Guaranteed minimum death benefits | ||||
GMIB | Guaranteed minimum income benefits | ||||
GMWB | Guaranteed minimum withdrawal benefits | ||||
LIMRA | Life Insurance Marketing and Research Association | ||||
NDGL | Net derivative gains (losses) | ||||
NIGL | Net investment gains (losses) | ||||
RBC | Risk-based capital | ||||
TAC | Total adjusted capital | ||||
ULSG | Universal life insurance with secondary guarantees | ||||
VA | Variable annuity | ||||
VOBA | Value of business acquired |
Financial Supplement | A-7 |
Reconciliation of Net Income (Loss) Available to Shareholders to Adjusted Earnings and Adjusted Earnings, Less Notable Items, and Reconciliation of Net Income (Loss) Available to Shareholders per Common Share to Adjusted Earnings per Common Share and Adjusted Earnings, Less Notable Items per Common Share (Unaudited, in millions except per share data)
For the Three Months Ended | ||||||||||||||||||||||||||||||||
ADJUSTED EARNINGS, LESS NOTABLE ITEMS | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Net income (loss) available to shareholders | $361 | $10 | $(610) | $(1,045) | $(3,012) | |||||||||||||||||||||||||||
Less: Net investment gains (losses) | (16) | (34) | 14 | 326 | 5 | |||||||||||||||||||||||||||
Less: Net derivative gains (losses), excluding investment hedge adjustments | 50 | (689) | (1,509) | (2,415) | (1,862) | |||||||||||||||||||||||||||
Less: GMIB Fees and GMIB Costs | (83) | 75 | 122 | 236 | (957) | |||||||||||||||||||||||||||
Less: Amortization of DAC and VOBA | (64) | 128 | 84 | 280 | (86) | |||||||||||||||||||||||||||
Less: Market value adjustments and other | 2 | (19) | 31 | 11 | (41) | |||||||||||||||||||||||||||
Less: Provision for income tax (expense) benefit on reconciling adjustments | 22 | 114 | 263 | 328 | 618 | |||||||||||||||||||||||||||
Adjusted earnings | 450 | 435 | 385 | 189 | (689) | |||||||||||||||||||||||||||
Less: Notable items | (64) | (23) | (43) | (83) | (1,077) | |||||||||||||||||||||||||||
Adjusted earnings, less notable items | $514 | $458 | $428 | $272 | $388 | |||||||||||||||||||||||||||
ADJUSTED EARNINGS, LESS NOTABLE ITEMS PER COMMON SHARE (1), (2) | ||||||||||||||||||||||||||||||||
Net income (loss) available to shareholders per common share | $4.34 | $0.11 | $(6.96) | $(11.69) | $(32.49) | |||||||||||||||||||||||||||
Less: Net investment gains (losses) | (0.19) | (0.40) | 0.16 | 3.65 | 0.05 | |||||||||||||||||||||||||||
Less: Net derivative gains (losses), excluding investment hedge adjustments | 0.60 | (8.01) | (17.23) | (27.03) | (20.09) | |||||||||||||||||||||||||||
Less: GMIB Fees and GMIB Costs | (1.00) | 0.87 | 1.39 | 2.64 | (10.32) | |||||||||||||||||||||||||||
Less: Amortization of DAC and VOBA | (0.77) | 1.49 | 0.96 | 3.13 | (0.93) | |||||||||||||||||||||||||||
Less: Market value adjustments and other | 0.02 | (0.22) | 0.35 | 0.12 | (0.44) | |||||||||||||||||||||||||||
Less: Provision for income tax (expense) benefit on reconciling adjustments | 0.26 | 1.32 | 3.00 | 3.67 | 6.67 | |||||||||||||||||||||||||||
Less: Impact of inclusion of dilutive shares | — | — | 0.03 | 0.02 | — | |||||||||||||||||||||||||||
Adjusted earnings per common share | 5.41 | 5.05 | 4.36 | 2.10 | (7.43) | |||||||||||||||||||||||||||
Less: Notable items | (0.77) | (0.27) | (0.49) | (0.92) | (11.62) | |||||||||||||||||||||||||||
Adjusted earnings, less notable items per common share | $6.17 | $5.32 | $4.86 | $3.03 | $4.19 | |||||||||||||||||||||||||||
(1) See definitions for Non-GAAP and Other Financial Disclosures in this Appendix. | ||||||||||||||||||||||||||||||||
(2) Per share calculations are on a diluted basis and may not recalculate or foot due to rounding. For loss periods, dilutive shares were not included in the calculation as inclusion of such shares would have an anti-dilutive effect. |
Financial Supplement | A-8 |
Reconciliation of Return on Common Equity to Adjusted Return on Common Equity (Unaudited, dollars in millions)
Four Quarters Cumulative Trailing Basis | ||||||||||||||||||||||||||||||||
ADJUSTED EARNINGS | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Net income (loss) available to shareholders | $(1,284) | $(4,657) | $(6,665) | $(1,105) | $(1,137) | |||||||||||||||||||||||||||
Less: Net investment gains (losses) | 290 | 311 | 311 | 278 | (15) | |||||||||||||||||||||||||||
Less: Net derivative gains (losses), excluding investment hedge adjustments | (4,563) | (6,475) | (8,443) | (36) | 482 | |||||||||||||||||||||||||||
Less: GMIB Fees and GMIB Costs | 350 | (524) | (724) | (1,012) | (1,214) | |||||||||||||||||||||||||||
Less: Amortization of DAC and VOBA | 428 | 406 | 527 | (228) | (415) | |||||||||||||||||||||||||||
Less: Market value adjustments and other | 25 | (18) | 25 | (49) | (43) | |||||||||||||||||||||||||||
Less: Provision for income tax (expense) benefit on reconciling adjustments | 727 | 1,323 | 1,743 | 220 | 253 | |||||||||||||||||||||||||||
Adjusted earnings | $1,459 | $320 | $(104) | $(278) | $(185) | |||||||||||||||||||||||||||
Five Quarters Average Stockholders' Equity Basis | ||||||||||||||||||||||||||||||||
BRIGHTHOUSE FINANCIAL, INC.’S COMMON STOCKHOLDERS’ EQUITY, EXCLUDING AOCI | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s stockholders’ equity | $16,690 | $17,666 | $18,518 | $18,749 | $18,683 | |||||||||||||||||||||||||||
Less: Preferred stock, net | 1,248 | 1,137 | 947 | 758 | 568 | |||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s common stockholders’ equity | 15,442 | 16,529 | 17,571 | 17,991 | 18,115 | |||||||||||||||||||||||||||
Less: AOCI | 4,674 | 4,809 | 4,420 | 4,390 | 3,960 | |||||||||||||||||||||||||||
Brighthouse Financial, Inc.’s common stockholders’ equity, excluding AOCI | $10,768 | $11,720 | $13,151 | $13,601 | $14,155 | |||||||||||||||||||||||||||
Five Quarters Average Common Stockholders' Equity Basis | ||||||||||||||||||||||||||||||||
ADJUSTED RETURN ON COMMON EQUITY | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Return on common equity | (8.3)% | (28.2)% | (37.9)% | (6.1)% | (6.3)% | |||||||||||||||||||||||||||
Return on AOCI | (27.5)% | (96.8)% | (150.8)% | (25.2)% | (28.7)% | |||||||||||||||||||||||||||
Return on common equity, excluding AOCI | (11.9)% | (39.7)% | (50.7)% | (8.1)% | (8.0)% | |||||||||||||||||||||||||||
Less: Return on net investment gains (losses) | 2.7% | 2.7% | 2.4% | 2.1% | (0.1)% | |||||||||||||||||||||||||||
Less: Return on net derivative gains (losses), excluding investment hedge adjustments | (42.4)% | (55.2)% | (64.2)% | (0.3)% | 3.4% | |||||||||||||||||||||||||||
Less: Return on GMIB Fees and GMIB Costs | 3.3% | (4.5)% | (5.5)% | (7.4)% | (8.6)% | |||||||||||||||||||||||||||
Less: Return on amortization of DAC and VOBA | 4.0% | 3.5% | 4.0% | (1.7)% | (2.9)% | |||||||||||||||||||||||||||
Less: Return on market value adjustments and other | 0.2% | (0.2)% | 0.1% | (0.4)% | (0.3)% | |||||||||||||||||||||||||||
Less: Return on provision for income tax (expense) benefit on reconciling adjustments | 6.8% | 11.3% | 13.3% | 1.6% | 1.8% | |||||||||||||||||||||||||||
Adjusted return on common equity | 13.5% | 2.7% | (0.8)% | (2.0)% | (1.3)% |
Financial Supplement | A-9 |
Reconciliation of Total Revenues to Adjusted Revenues and Reconciliation of Total Expenses to Adjusted Expenses (Unaudited, in millions)
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | September 30, 2021 | September 30, 2020 | ||||||||||||||||||||||||||||||||||||||
Total revenues | $2,512 | $1,676 | $938 | $131 | $309 | $5,126 | $8,372 | |||||||||||||||||||||||||||||||||||||
Less: Net investment gains (losses) | (16) | (34) | 14 | 326 | 5 | (36) | (48) | |||||||||||||||||||||||||||||||||||||
Less: Net derivative gains (losses) | 56 | (684) | (1,504) | (2,410) | (1,857) | (2,132) | 2,392 | |||||||||||||||||||||||||||||||||||||
Less: GMIB Fees | 62 | 63 | 62 | 63 | 68 | 187 | 196 | |||||||||||||||||||||||||||||||||||||
Less: Investment hedge adjustments | (6) | (5) | (5) | (5) | (5) | (16) | (13) | |||||||||||||||||||||||||||||||||||||
Less: Other | (1) | (2) | — | 11 | (1) | (3) | — | |||||||||||||||||||||||||||||||||||||
Total adjusted revenues | $2,417 | $2,338 | $2,371 | $2,146 | $2,099 | $7,126 | $5,845 | |||||||||||||||||||||||||||||||||||||
Total expenses | $2,022 | $1,655 | $1,706 | $1,437 | $4,152 | $5,383 | $8,485 | |||||||||||||||||||||||||||||||||||||
Less: Amortization of DAC and VOBA | 64 | (128) | (84) | (280) | 86 | (148) | 508 | |||||||||||||||||||||||||||||||||||||
Less: GMIB Costs | 145 | (12) | (60) | (173) | 1,025 | 73 | 1,444 | |||||||||||||||||||||||||||||||||||||
Less: Other | (3) | 17 | (31) | — | 40 | (17) | 60 | |||||||||||||||||||||||||||||||||||||
Total adjusted expenses | $1,816 | $1,778 | $1,881 | $1,890 | $3,001 | $5,475 | $6,473 |
Financial Supplement | A-10 |
Investment Reconciliation Details (Unaudited, dollars in millions)
For the Three Months Ended | For the Nine Months Ended | |||||||||||||||||||||||||||||||||||||||||||
NET INVESTMENT GAINS (LOSSES) | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | September 30, 2021 | September 30, 2020 | |||||||||||||||||||||||||||||||||||||
Investment portfolio gains (losses) | $(12) | $(28) | $16 | $329 | $2 | $(24) | $(9) | |||||||||||||||||||||||||||||||||||||
Investment portfolio writedowns | (4) | (6) | (2) | (3) | 3 | (12) | (39) | |||||||||||||||||||||||||||||||||||||
Net investment gains (losses) | $(16) | $(34) | $14 | $326 | $5 | $(36) | $(48) |
For the Three Months Ended | ||||||||||||||||||||||||||||||||
NET INVESTMENT INCOME YIELD | September 30, 2021 | June 30, 2021 | March 31, 2021 | December 31, 2020 | September 30, 2020 | |||||||||||||||||||||||||||
Investment income yield (1) | 5.29% | 5.21% | 5.25% | 4.70% | 4.56% | |||||||||||||||||||||||||||
Investment fees and expenses (2) | (0.13)% | (0.13)% | (0.13)% | (0.14)% | (0.14)% | |||||||||||||||||||||||||||
Net investment income yield | 5.16% | 5.08% | 5.12% | 4.56% | 4.42% | |||||||||||||||||||||||||||
(1) Yields are calculated on investment income as a percent of average quarterly asset carrying values. Investment income includes investment hedge adjustments, excludes realized gains and losses and reflects the GAAP adjustments described beginning on page A-2 of this Appendix. Asset carrying values exclude unrealized gains (losses), collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties. | ||||||||||||||||||||||||||||||||
(2) Investment fee and expense yields are calculated as investment fees and expenses as a percent of average quarterly asset estimated fair values. Asset estimated fair values exclude collateral received in connection with our securities lending program, freestanding derivative assets and collateral received from derivative counterparties. |